What the FDA’s Moderna rejection means for every vaccine maker
The Food and Drug Administration’s refusal to review Moderna’s flu vaccine this month has renewed fears that Trump…
Moderna’s president weighs in on FDA’s decision not to review its flu vaccine
Food and Drug Administration officials told Moderna in August that they would review its application for a new…
Prasad takes a familiar, conservative approach to drug approvals
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Sanofi replaces Paul Hudson as CEO with Belén Garijo
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Prasad overruled FDA staff to reject Moderna flu vaccine application
WASHINGTON — Top Food and Drug Administration official Vinay Prasad overruled the agency’s reviewers when he refused to accept…
FDA refuses to review Moderna’s flu vaccine application
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her…
FDA rejects Regenxbio’s MPS II rare-disease gene therapy
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TrumpRx promises cheapest drugs. Many cost less already
WASHINGTON — President Trump said his administration’s new TrumpRx website will offer the cheapest prices in the world…
Hims & Hers won’t sell compounded version of Novo’s obesity pill
Hims & Hers said Saturday it will stop selling what it claims to be a cheaper, compounded version…
Clemson Announces 2026 Football Schedule – Clemson Tigers Official Athletics Site
GAME-BY-GAME SATURDAY, SEPT. 5 • AT LSU • TIGER STADIUM, BATON ROUGE, LA. Clemson and LSU faced one…
Greenland’s capital restores power, heating after storm damaged line
Item 1 of 4 A bartender works in a bar during a city-wide power outage that local utility…
Why a week without blockbuster M&A was actually fantastic
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…